[go: up one dir, main page]

WO2003066137A1 - Surveillance de la temperature cerebrale - Google Patents

Surveillance de la temperature cerebrale Download PDF

Info

Publication number
WO2003066137A1
WO2003066137A1 PCT/SE2003/000187 SE0300187W WO03066137A1 WO 2003066137 A1 WO2003066137 A1 WO 2003066137A1 SE 0300187 W SE0300187 W SE 0300187W WO 03066137 A1 WO03066137 A1 WO 03066137A1
Authority
WO
WIPO (PCT)
Prior art keywords
blood
catheter
brain
infusion
temperature
Prior art date
Application number
PCT/SE2003/000187
Other languages
English (en)
Inventor
Mats Allers
Anders Lunderquist
Fredrik BORIS-MÖLLER
Tadeusz Wieloch
Original Assignee
Argmed Kb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/072,857 external-priority patent/US20020161349A1/en
Application filed by Argmed Kb filed Critical Argmed Kb
Priority to EP03703603A priority Critical patent/EP1480693A1/fr
Priority to CA002476382A priority patent/CA2476382A1/fr
Priority to AU2003206313A priority patent/AU2003206313A1/en
Priority to US10/502,574 priority patent/US20060052854A1/en
Publication of WO2003066137A1 publication Critical patent/WO2003066137A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/12—Devices for heating or cooling internal body cavities
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/12—Devices for heating or cooling internal body cavities
    • A61F2007/126—Devices for heating or cooling internal body cavities for invasive application, e.g. for introducing into blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/369—Temperature treatment

Definitions

  • the present invention relates to a method and equipment for controlling the temperature of a brain of a living being.
  • the body temperature or the temperature of the body parts of a living being influences the healing process and the risk of permanent damage.
  • Cancer cells are heat sensitive and a local heating of the blood flow around a cancer tumor may for some types of cancer constitute a treatment resulting in restrained tumor growth, or in some cases even in a shrinking of the tumor. In other cases cooling of a body part may be important to reduce adverse secondary symptoms of the pathological condition.
  • the blood flow in the brain is reduced due to a hemorrhage or the clogging of a blood vessel. This condition is critical and it is important that treatment is initiated at an early stage, to reduce the loss of bodily functions, such as paralysis.
  • cooling the brain effectively blocks the development of cellular damage after an episode of ischemia. Cooling of the patient therefore also results in a reduction of the symptoms of neurological deficit.
  • the cooling takes a considerable amount of time, another that it must be carried out under close control of vital signs or under anesthesia, and a third that there is a risk of cardiovascular complications.
  • the brain can suffer permanent damage if the arrest exceeds a time period of about 5-15 minutes.
  • the temperature of the brain is lowered before or after the arrest the brain damage is diminished. This may also be applied to the situation of neonatal asphyxia.
  • the U.S. Pat. No. 5,906,588 discloses a method and a device for heart-lung bypass and cooling of a specific body part. This disclosure primarily relates to complicated heart surgery and organ transplantation. Today there is no safe and simple method disclosed for a rapid induction of brain hypothermia in ischemic disease.
  • a purpose of the present invention is to provide a system and a method for quick and efficient control of the temperature of the brain and a route for fast delivery of drugs to the brain.
  • An aim of the invention is to provide a system and a method that is simple and initially does not require specialized personnel acquainted with for example radiology or other diagnostic imaging techniques.
  • Another purpose of the invention is to provide a system and a method for quick and simple temperature control that also supports subsequent diagnostic measures such as magnetic resonance imaging (MRI), i.e. temperature control without inserting metal components into the body of the patient.
  • MRI magnetic resonance imaging
  • Yet another purpose of the invention is to provide a system and a method for maintaining the temperature control of the brain.
  • a first phase cf. FIG. la
  • a second infusion catheter is introduced into an artery of the living being.
  • the second infusion catheter is configured to provide selective temperature control of the brain and infusion of other important substrates and pharmacological compounds into the brain. This accomplishes a quick temperature change in the brain, involving only a comparatively minor procedure.
  • the brain and thus also the affected brain hemisphere can be cooled quickly according to the method of the invention, resulting in a reduction of the symptoms of functional loss.
  • continued cooling is maintained in order to keep the temperature of the brain lowered for as long as it takes to diagnose, medicate and restore the functions of the ischemic brain section.
  • a further embodiment and possibly a third phase of the invention involves cooling or heating of blood withdrawn from a living being before the blood is recycled to the living being.
  • an extra-corporeal circuit or conduit is established.
  • the extra-corporeal circuit is established between a vein, e.g. a vein in the lower part of the body, and an artery, e.g. the arteria carotis communis, sinister or dexter, arteria subclavia, brachiocephalic trunk, or some other artery, e.g. an artery that supplies blood to the brain, wherein the temperature of the blood is modified outside the body before the blood is returned to the body through the artery.
  • Another embodiment contains the method to reintroduce heated blood to the venous system in order to avoid whole body hypothermia.
  • This embodiment thus allows for heating a first part of the body at the same time as a second part, for example the brain, is cooled.
  • the system for performing this embodiment preferably comprises two separate flow branches or circuits, one for the cooling and one for the heating.
  • Yet another embodiment of the invention involves, in addition to cooling or heating the blood, controlling the oxygenation of the brain and the affected brain hemisphere, i.e. the blood is oxygenated or deoxygenated before it is returned to the body.
  • the invention comprises a system, equipment components and a method in inter alia the following aspects of the invention:
  • a method for brain hypothermia comprising, in a first phase to enable an early and fast onset of the hypothermia, the steps of:
  • Varieties of this method further comprises a second hypothermia phase for brain-selective hypothermia, wherein an arterial infusion catheter is inserted into an artery and a second amount of cold solution is infused into the arterial system, to enable a more efficient temperature regulation of the brain.
  • the arterial infusion catheter is inserted into a selected peripheral artery, e.g. an arteria radialis, arteria ulnaris or an arteria brachialis.
  • the method may further comprise the step of positioning a distal tip of said arterial infusion catheter in a selected central artery at the vicinity of a branch artery supplying blood to the brain.
  • the selected central artery is e.g. arteria subclavia at the vicinity of arteria carotis, truncus brachiocephalicus or ascending aorta. In some cases it may be necessary or improving to apply a pressure from the outside of the extremity with the peripheral artery for decreasing peripheral blood circulation. Further embodiments comprise the steps of:
  • the emergency phase may be directly followed by a hypothermia phase for maintained hypothermia, comprising the steps of:
  • a further developed embodiment comprises the steps of:
  • One embodiment comprises a third hypothermia phase for maintained hypothermia or follows the brain-selective hypothermia phase, the third hypothermia phase comprising the steps of: - inserting into a blood vessel an extraction catheter for extraction of blood;
  • an embodiment of the emergency phase method comprises the steps of:
  • An embodiment of an equipment for brain hypothermia in a living being comprises:
  • a flexible elongated infusion catheter said catheter having a proximal end being attachable to an outlet of said container, said catheter having a sufficiently small diameter to be percutaneously insertable into a blood vessel and its tip forwarded to or into the vicinity of the blood vessel feeding the brain with blood so that the infusion solution will find its way to the brain.
  • An equipment for brain hypothermia comprising, to enable an early and fast onset of the hypothermia:
  • said venous infusion catheter having a distal end devised to be percutaneously inserted into a peripheral vein;
  • cooling device being configured for cooling the infusion solution to a second temperature lower than said first temperature
  • cooling device configured for cooling the infusion solution to a second temperature in the range of 0-37 degrees Celsius
  • cooling device is configured for cooling the infusion solution to a second temperature in the range of 0-4 degrees Celsius;
  • the infusion catheter is configured to be inserted into a median cubital vein;
  • the infusion catheter is configured to be inserted into a saphenous vein
  • the infusion solution is a hypotonic saline solution
  • said first amount of infusion solution is in the range of 1-2 liters or in the range of 10-60 ml/kg;
  • the infusion solution has an altered osmolarity, e.g. a low osmolarity, in order to lessen the circulatory volume load of the infusion solution when infused into the patient; - wherein the infusion solution is provided in a container that is air-sealed at steady state at a temperature in the range of 37 degrees Celsius;
  • An embodiment for equipment configured use in a brain-selective hypothermia phase comprises an arterial infusion catheter configured to be inserted into an artery and a container with a second amount of cold solution configured to be infused into the arterial system, to enable a more efficient temperature regulation of the brain in a second hypothermia phase for brain-selective hypothermia.
  • this equipment the arterial infusion catheter is configured to be inserted into a selected peripheral artery;
  • Embodiments may further comprise a device for applying a pressure from the outside of the extremity with the peripheral artery for decreasing peripheral blood circulation. Further embodiments further comprises:
  • a temperature sensor configured to be percutaneously inserted in a blood vessel draining blood from the brain; and being configured to: - sensing the temperature in the blood of said blood vessel thus providing an indication of the temperature in the brain;
  • a further developed embodiment is followed by a third hypothermia phase for maintained hypothermia, and comprises:
  • an extraction catheter being configured to be inserted into a blood vessel for extraction of blood
  • an arterial infusion catheter being configured to be inserted into the vicinity of an artery supplying blood to the brain;
  • - coupling means for establishing a first extra-corporeal blood circuit for cooled blood between said extraction catheter and said arterial infusion catheter via a pumping means and a temperature regulating device capable of cooling extracted blood; and being configured to: - extracting blood from said blood vessel via said extraction catheter leading a first amount of said extracted blood into said first extra-corporeal blood circuit;
  • a venous infusion catheter being configured to be inserted into a vein of the venous system; and further being configured to:
  • a temperature sensor would be configured to adjusting the infusion rate of said cooled blood dependent on said sensed temperature for achieving a desired temperature in the brain; or to adjusting the temperature of said cooled blood dependent on said sensed temperature for achieving a desired temperature in the brain.
  • An embodiment of an equipment for brain hypothermia comprises, to enable a brain-selective hypothermia:
  • a distal end of said arterial infusion catheter being configured to be percutaneously inserted into an artery in or in the vicinity of a branch artery supplying blood to the brain;
  • a cooling device configured to cooling the infusion solution to a second temperature lower than said first temperature, to enable the cold infusion solution to cool the blood flowing to the brain while avoiding air bubbles arising in the infusion solution and an efficient temperature regulation of the brain.
  • An embodiment of equipment for brain hypothermia comprises, to enable a maintained hypothermia: - an extraction catheter configured to be inserted into a blood vessel for extraction of blood;
  • an arterial infusion catheter configured to be inserted in an artery into the vicinity of an artery supplying blood to the brain
  • a venous infusion catheter being configured to be inserted into a vein of the venous system
  • a cooling device for cooling a second amount of said extracted blood
  • a heating device for heating a first amount of said extracted blood
  • a basic embodiment of an equipment for brain hypothermia comprises:
  • a distal end of said infusion catheter being configured to be percutaneously inserted into a blood vessel that supplies the brain with blood;
  • a specifically developed catheter wherein: the catheter being configured to assume a curvature at its distal part; comprises - a first lumen having a plurality of openings positioned close to a distal end of the catheter and at the outer arc of the curvature;
  • FIG. la is a block diagram indicating three phases for regulating the brain temperature according to embodiments of the invention.
  • FIG. lb is a block diagram indicating the steps of a method according to one embodiment of the invention.
  • FIG. 2 is a schematic illustration of an example of a first embodiment of the system according to the invention, here also called the emergency whole body control phase;
  • FIG. 3a is a block diagram indicating the steps of a method according to one embodiment of the invention.
  • FIG. 3b illustrates schematically an example of how a catheter is arranged in the arteria subclavia dexter, in a second embodiment of the system according to the invention, here also called the brain selective temperature control phase;
  • FIG. 4 is a block diagram indicating the steps of a method according to one embodiment of the invention.
  • FIG. 5 shows schematically an example of a double lumen catheter applicable in embodiments of the invention
  • FIG. 6a illustrates schematically a first example of a the inventive system configured in an embodiment here called the maintained temperature control phase
  • FIG. 6b illustrates schematically a second embodiment of the inventive system configured in an embodiment of the maintained temperature control phase
  • FIG. 6c illustrates schematically a third embodiment of the inventive system configured in an embodiment of the maintained temperature control phase
  • FIG. 7a, 7b and 7c show schematically embodiments of a temperature regulating device
  • FIG. 8 illustrates schematically an embodiment of an extra-corporeal blood circuit comprising a shunt
  • FIG 9 shows schematically an example of a triple lumen catheter applicable in embodiments of the invention.
  • the present invention relates to a method, a system and a set of disposable equipment components for controlling the temperature of the brain of a living being. More specifically the present invention refers to a method, a system, and a set of disposable equipment for accomplishing a simple, quick and efficient control of the temperature of a brain.
  • the method according to the invention for accomplishing control of the temperature of the brain and maintaining the control of the temperature during a predetermined period of time can be divided into three phases or procedures. Firstly, an emergency whole body temperature control phase, secondly, a brain selective temperature control phase and thirdly, a maintained temperature control phase.
  • the invention will be explained by reference to examples of embodiments thereof, primarily relating to cooling the brain in a case of stroke, trauma or neonatal asphyxia, or before, during or after a circulatory arrest in a human patient.
  • the control of the temperature is performed in conjunction with another treatment procedure, such as infusion or inhalation of pharmaceuticals, a gas or a gas mixture, respectively that have brain protective properties.
  • gases are different anaesthetic gases such as Isofluran or hydrogen gas.
  • substances having brain protective properties it is here understood such substances that: - decreases the effects of the occurrence of free radicals, that is a substance scavenging free radicals;
  • the perfusion may initially consist of some perfusion solution, such as a saline solution, Ringer's lactate or Ringer's acetate, containing an antioxidant or a drug, followed in a second stage by thermally regulated blood which is returned to the patient.
  • a compression cuff such as a tourniquet or the like, is placed on the arm in question, i.e. the arm into which the device for returning the blood is inserted, in order to suppress peripheral circulation and to increase the pressure in the blood vessel, making the pressure of the returning blood equal to the pressure exerted by the heart on the blood, which in consequence results in a flow velocity of 10-12 ml/s.
  • the flow velocity may optionally be regulated in such a way as to make the blood in the arteria vertebralis dexter and the arteria carotis dexter perfuse with a spill-over to the arcus aortae, the flow along the aorta curvatura major being laminar. This is desirable in order to allow the maximum share of the spill-over to reach the aorta carotis sinister. The above arrangement will prevent flow backwards toward the valvular section.
  • diagnostic work can be initiated, such as magnetic resonance imaging, or some other form of diagnostic examination, without having to abort the thermal regulation as described above.
  • the desired temperature for example 32 degrees Celsius
  • the thermal regulation described is aborted, and the temperature reached can be maintained using conventional cooling blankets or the like.
  • a simple and quick initial control of the temperature of the brain and the body is achieved by the emergency temperature control phase comprising in more general terms the step of initiating as soon as possible an intravenous infusion of a solution that has a controlled temperature, into a blood vessel of the living being by for example ambulance personnel or other nursing staff.
  • a temperature controlled solution to the body of a human being in the amount of about 10-60 ml/kg, e.g. 1 to 3 liters, or even more.
  • the solution is for example a saline solution possibly comprising antioxidant or other pharmaceuticals having anti-ischaemic properties or suppressing inflammatory processes.
  • inhalation of selected gases can be provided, which gases may have brain-protective properties. Examples of gases or gas mixtures could be different anaesthetic gases such as Isofluran or hydrogen gas.
  • the infusion solution is preferably a cold or ice cold solution, e.g., a saline solution possibly comprising an antioxidant.
  • FIG. lb cf. Fig. 2 the steps of:
  • an infusion catheter into a selected peripheral blood vessel, preferably a vein 206 such as the median cubital vein 206 or saphenous vein, or a central blood vessel 208, 210, 212, 214 such as the jugular vein 210, 214 or the subclavian vein 208, 212; 1102 positioning the tip of the infusion catheter as close to the venous inlet of the heart as possible without getting adverse cardiac effects of the quick infusion of a temperature controlled solution; 1104 controlUng or regulating the temperature, e.g. cooling, of an infusion solution by means of a temperature regulating means, e.g.
  • a temperature regulating means e.g.
  • a cooling means 1106 infusing the temperature controlled infusion solution, e.g., a cold or ice cold saline solution, preferably having an altered osmolarity, e.g. a low osmolarity, and comprising for example ischemic protective pharmaceuticals into the blood vessel.
  • the temperature controlled infusion solution e.g., a cold or ice cold saline solution, preferably having an altered osmolarity, e.g. a low osmolarity, and comprising for example ischemic protective pharmaceuticals into the blood vessel.
  • One embodiment may also possibly comprise the step of
  • an infusion catheter is introduced, preferably percutaneously, into a selected blood vessel, preferably a vein, of the living being such as the median cubital vein, saphenous vein, cephalic vein or basilic vein.
  • a selected blood vessel preferably a vein
  • the chosen venous catheter is designed such and of the type that the involved personnel are well acquainted with.
  • the inner diameter of the infusion catheter is typically in the range of 1-4 mm, preferably in the range of 2-3 mm, and the length of the infusion catheter is at least about 3 cm.
  • the tip positioning according to step 1102 is preferably performed by means of indication means such as markings arranged on the outer surface of the infusion catheter or small diameter- changes of the catheter, whereby the indication means indicates the length of the catheter that has been introduced into the living being.
  • the position of the catheter tip can be determined without the use of any imaging techniques.
  • the temperature of the infusion solution is regulated or controlled, i.e. the infusion solution is temperature controlled.
  • the infusion solution is preferably a cooled hypotonic saline solution, i.e. a saline solution having an osmotic pressure lower than the blood.
  • An infusion solution having a low osmolarity is preferably chosen in order to lessen the circulatory volume load of the infusion solution.
  • infusion solution having a temperature in the range of 0- 37 degrees Celsius, preferably 0-10 degrees Celsius, more preferably in the range of 0-4 degrees Celsius, can be infused, whereby a lowered body and brain temperature is achieved.
  • it is sufficient to infuse an infusion solution having a temperature in the range of 10-37 degrees Celsius since infusion of a infusion solution having a temperature lower than the body temperature will cause a decreased brain temperature.
  • the infusion solution is cooled by means of a peltier element, i.e. an apparatus which by means of electricity, produces cooling of a metal part in an electrical circuit which metal part cools the infusion solution.
  • a peltier element i.e. an apparatus which by means of electricity, produces cooling of a metal part in an electrical circuit which metal part cools the infusion solution.
  • suitable cooling means can also be used.
  • a container comprising the infusion solution can be placed in an icebox or in a container comprising ice or ice cubes.
  • a cooled infusion solution in steady state with the atmospheric pressure may give rise to gas bubbles or air bubbles of different sizes when supplied to a patient, due to the lower gas solubility at higher temperatures. Such air bubbles may be very harmful to the patient if they are conveyed to the brain.
  • Another way of avoiding or decreasing the amount of air bubbles is to provide the infusion solution in a sealed or air-sealed container, for example in a sealed container manufactured of a gas impermeable plastic or a plastic-like material, and sealing performed at steady state at a temperature in the range of 37 degrees Celsius.
  • the infusion solution is infused to venous blood by means of the infusion catheter, whereby a lowered body temperature is achieved.
  • the body temperature is decreased by one to two degrees Celsius when one to two liters of cooled infusion solution is infused.
  • the infusion speed or velocity can be varied for example by applying a pressure on the container or plastic bag comprising the infusion solution, but the infusion speed should preferably be as large as possible. However, the infusion speed depends on the dimensions of the infusion catheter.
  • a gas or a gas mixture having brain protective properties is inhaled through for example a facial mask.
  • gases are different anaesthetic gases such as NO, Isofluran and hydrogen gas.
  • substances having brain protective properties it is here understood such substances that:
  • FIG. 2 shows this embodiment of the invention applied in a human patient for cooling the brain.
  • a container 201 for example a plastic bag, having a temperature controlled infusion solution 202, is coupled to an infusion catheter 204.
  • the infusion solution is cooled in a cooler 203 before use or is maintained in a cooling box 205.
  • the infusion catheter is percutaneously introduced into the right median vein 206 and inserted as close to the venous inlet of the heart as possible without getting adverse cardiac effects due to a quick infusion of a cooled infusion solution.
  • the treatment would be analogue but of course with a heated infusion solution.
  • the brain-selective temperature control phase may be achieved, either as a complement to the emergency whole body temperature control procedure or as separate temperature control procedure.
  • the brain-selective temperature control phase comprises the steps of: 1200 possibly introducing by surgical cut-down or percutaneously with e.g. Seldinger technique a guide wire-catheter system into a selected relatively peripheral artery, for example arteria radialis, arteria ulnaris or arteria brachialis to provide a high amount of cooled infusion to the brain;
  • an arterial infusion catheter into the selected artery, for example arteria radialis or arteria brachialis by means of a guide- wire; 1204 positioning the tip of the arterial infusion catheter in a selected relatively central or brain close artery, preferably in the right arteria subclavia, truncus brachiocephalica, the ascending aorta, arteria carotis communis or in another selected artery;
  • a temperature sensor such as a thermistor or a thermocouple
  • the temperature sensor is preferably coupled to an externally arranged display means displaying the measured temperature of the blood in the brain draining blood vessel, e.g. the jugular vein(s); 1210 infusing a temperature controlled solution, e.g., a cold or ice cold saline solution, preferably having an altered osmolarity, e.g.
  • a supplying means such as a pumping means, e.g., a perfusion pump, to the selected site of infusion
  • 1212 checking the temperature of the brain or the affected brain hemisphere by means of the temperature sensor sensing the temperature in the blood flow in the respective brain draining blood vessels, e.g. the respective jugular vein, thus being dependent on the brain temperature
  • 1214 adjusting the infusion speed or the infusion rate, i.e. the amount of the temperature controlled infusion solution supplied per unit of time, so that a desired and predetermined temperature is achieved in the brain or the affected brain hemisphere, thus preferably dependent on the sensed temperature.
  • a guide wire-catheter system is possibly introduced, percutaneously or by surgical cut-down, into a selected blood vessel supplying blood to the brain.
  • the catheter is introduced into the right arteria radialis or- the right arteria brachialis, and advanced to the predetermined position, whereby a high concentration of cooled blood can be supplied to the brain.
  • a device for infusion of an infusion fluid preferably consisting of a guide wire and a heparinized and hydrophilic arterial infusion catheter is inserted.
  • the tip of the arterial infusion catheter is in step 1204 positioned in for example the right arteria subclavia, arteria brachiocephalica or in the ascending aorta.
  • An external pressure is possibly applied in step 1206 on the arm used for the arterial infusion catheter.
  • the pressure is preferably achieved by means of a pressure means, for example by applying a circumferential tourniquet around the selected arm, the pressure means can further be arranged for cooling the arm or for preventing peripheral circulation of blood.
  • the temperature sensor is preferably coupled to an externally arranged display means displaying the measured temperature of the blood in the jugular vein(s) to an operator. It should be understood that measurement of the temperature is preferably performed in the internal jugular vein since this will more accurately reflect the temperature of the brain or brain hemisphere.
  • a temperature controlled infusion solution e.g. a cold or icecold saline solution, is infused into the selected artery by means of the arterial infusion catheter and a supplying means, such as a pumping means, e.g. a perfusion pump.
  • step 1212 the temperature of the brain or the affected brain hemisphere is controlled by means of the temperature sensor, and in step 1214, the infusion speed of the infusion solution is adjusted to achieve a desired and predetermined temperature in the brain or the affected brain hemisphere.
  • the surface of the arterial infusion catheter is preferably coated with an anticoagulant compound to prevent coagulation of blood on the catheter surface and in the surroundings of the arterial infusion catheter.
  • the arterial infusion catheter has an externally arranged indication means, such as markings or diameter-changes, in order to indicate the position of the catheter tip in the selected artery, e.g. the right arteria subclavia, truncus brachiocephalicus or ascending aorta.
  • FIG. 3b shows schematically an example of this embodiment of the invention applied in the arterial system of a human patient.
  • a container 301 containing a temperature controlled infusion solution 302 is connected to an arterial infusion catheter 304.
  • the infusion solution 302 is tempered in a cooler or heater 303 or has a pre-arranged temperature that is maintained by means of a cooling or heating box 305. Most examples in the specification are however directed to cooling.
  • the infusion catheter 304 is inserted into the right radial artery 306 with its distal end outlet introduced up the right subclavian artery 308 in a position at level with the inlet of the right carotid artery 318.
  • a low infusion flow rate will cause the infusion solution to flow up into the right common carotid 318. If the infusion rate is increased a part of the infusion solution will flow up into the right common carotid 318 and another part of the infusion solution will flow down into the ascending aorta 314 and up into the left common carotid 320. However, if the infusion rate is increased even more, the infusion solution will flow down into the coronary arteries, which should be avoided because of possible detrimental effects on the cardiac performance.
  • the infusion catheter 304 is inserted via the right arteria subclavia 308 into the truncus brachiocepahlica 316.
  • a low infusion rate will cause the infusion solution to flow up into the right common carotid 318. If the infusion rate is increased a part of the infusion solution will flow up into the right common carotid 318 and another part will flow into the ascending aorta 314 and up into the left common carotid 320. However, if the velocity of the infusion solution is increased further, the infusion solution will flow down into the coronary arteries, which should be avoided because of possible detrimental effects on the cardiac performance.
  • the infusion catheter 304 is introduced via for example the left arm and the left arteria subclavia 310 into the ascending aorta 314.
  • the infusion solution will flow up into the left and right common carotids, 320 and 318, respectively.
  • the infusion catheter 304 is introduced into the ascending aorta 314 via arteria femoralis and the aortic arch 312, whereby the supplied infusion solution flows up in the left and right common carotid, 320 and 318, respectively.
  • This infusion catheter can for example be a double lumen catheter as described below.
  • a temperature sensor 324 is introduced into a jugular vein 322, whereby the temperature of the blood from the brain hemisphere can be monitored and thus a measure of the temperature in the brain is achieved.
  • the infusion catheter 304 is coupled to a perfusion apparatus that generates a pulsating flow of infusion solution. This pulsating flow is then synchronized to the heart cycle such that the cool infusion solution flows up in the left and right carotids, 320 and 318, respectively, when the heart is in systole, i.e. when the heart is contracting and pumping blood to the arteries.
  • the infused solution has a temperature in the interval of 0-37 degrees Celsius or in the interval of 0-20 degrees Celsius, preferably in the interval of 0-10 degrees Celsius, and most preferably in the interval of 0-4 degrees Celsius.
  • the infusion solution is held or stored in room temperature or preferably at 37 degrees Celsius and is quickly cooled just before the start of the infusion procedure to decrease or avoid the risk of formation of gas or air bubbles in the blood vessel when the infusion solution is infused.
  • the infusion has an altered osmolarity, e.g. a low osmolarity in order to lessen the circulatory volume load of the infusion solution.
  • a brain temperature in the interval of 15 to 37 degrees Celsius is desirable, but in other cases a brain temperature in the range of 30-37 degrees Celsius is desirable.
  • a brain temperature in the range of 27 to 35 degrees Celsius is desired and more preferably a brain temperature of approximately 33 degrees Celsius.
  • a temperature about 30-35 degrees Celsius in the brain or the affected brain hemisphere can be achieved after about 2-8 minutes, by supplying a cooled infusion solution of a temperature in the range of 0-4 degrees Celsius at a speed in the range of 300-700 milliliters per minute.
  • a speed in the range of 50-700 milliliters per minute is suitable.
  • the achieved temperature, time and flow rate are probably dependent on body size of the patient as well as on the infusion rate.
  • the flow velocity of the infusion solution can optionally be regulated in a way making the blood in the arteria vertebralis dexter and the arteria carotis dexter to perfuse with a spill-over to the arcus aortae and to flow along the aorta curvatura major into the left carotic artery. This is desirable in order to allow the maximum share of the spill-over to reach the aorta carotis sinister. The above arrangement will prevent flow backwards towards the valvular section.
  • the maintained temperature control procedure i.e., the procedure for maintaining the desired level of selected brain hypothermia or hyperthermia, can either be accomplished during or after the whole body temperature control procedure or the brain- selective temperature control procedure described above.
  • the maintained temperature control phase can be achieved by using for example a temperature regulated blanket or mattress or by establishing an extra- corporeal circulation of temperature regulated blood or another temperature regulated solution.
  • This phase is for example accompUshed in hospitals wherein immediate access to specialized personnel in cardiology and radiology is provided.
  • this phase comprises a method of establishing an extra-corporeal circulation of temperature controlled blood.
  • the method comprises: withdrawal or extraction of blood from a living being for example suffering of stroke, trauma, neonatal asphyxia or circulatory arrest, controlling or regulating the temperature of the blood, possibly also regulating the oxygenation of the blood, and reintroducing the blood into the living being.
  • the temperature of the brain and possibly the rest of the body are controlled.
  • One embodiment of the method comprises the establishment of two extra-corporeal circuits, namely a first circuit for cooling the brain and a second circuit for heating other parts of the body, e.g. for keeping the rest of the body at normal temperature.
  • a variety of this embodiment utiUzes a peltier element for cooling and the opposite side of the same peltier element for heating.
  • an embodiment of the method of establishing an extra- corporeal circulation of temperature controlled blood comprises the steps of (cf . FIG. 4): 1300 introducing, into a central vein or artery of a patient, an extraction catheter for extraction of blood;
  • 1302 possibly, introducing a venous infusion catheter into a vein of the patient; 1304 possibly, introducing an arterial infusion catheter into an artery of the patient, preferably to an artery supplying blood to the brain of the patient; 1306 possibly, introducing one or several temperature sensors into one or both jugular veins, whereby the temperature(-s) of the blood in the jugular vein(-s) can be measured;
  • 1308 connecting the extraction catheter to an arterial cannula, i.e. the arterial infusion catheter, via a perfusion pump, a heat exchanger and possibly also a regulator regulating the oxygenation of the blood, whereby an extra-corporeal circulation to an artery controlling the temperature of the brain is established; 1310 possibly also connecting the extraction catheter to the venous infusion catheter by means of for example a flow-dividing Y-connector, via a second perfusion pump and a heat exchanger, whereby an extra-corporeal circulation to the venous system is established; 1312 circulating venous or arterial blood extra-corporeally from the patient through the oxygenator and heat exchanger(-s), regulating or controlling the oxygenation and temperature of the blood, and back to the patient; 1314 reintroducing temperature controlled blood into the patient through the arterial infusion catheter arranged in an artery leading blood to the brain, whereby the reintroduced blood regulates the oxygenation and temperature of the brain; 1316 optionally, reintroducing temperature controlled blood into the patient through the
  • a blood extraction means is inserted into a suitable vein or artery, e.g., vena femoralis or arteria femoralis or vena jugularis.
  • the blood extraction device is in one embodiment of the invention an introducer or a first catheter.
  • an extraction catheter having an outer diameter smaller than the normal inner diameter of the vein or the artery, so as not to stop entirely the flow of blood around the extraction catheter, but large enough to give a sufficient flow of extracted blood.
  • the vein or artery is e.g. the vena femoralis or arteria femoralis or vena jugularis.
  • the catheter has in one embodiment of the invention, a conical extra-corporeal coupling for low flow resistance during perfusion.
  • This coupling is provided with a seal that can be perforated, for example by a guide wire and/or a dilator, to prevent unnecessary bleeding.
  • the seal can also be removed for attachment to an extra-corporeal circuit.
  • the catheter is heparinized internally and externally, to counteract coagulation of the blood that comes into contact with the catheter.
  • an infusion device is introduced possibly into a sufficiently large peripheral or central vein.
  • the infusion device is preferably an infusion catheter for the reintroduction or reinfusion of temperature regulated blood or for infusion of a treatment solution.
  • This infusion catheter is primarily intended for the reinfusion of possibly heated extra-corporeally circulated blood, whereby the undesirable cooling effects of the rest of the body may be postponed or completely counteracted.
  • an arterial infusion catheter is possibly introduced in a peripheral artery and its tip positioned into an artery supplying blood to the brain.
  • the arterial infusion catheter can be the one used in for example a previous selective brain temperature control phase, whereby it is not necessary to introduce another arterial infusion catheter.
  • another arterial infusion catheter can optionally be introduced, for example a double lumen catheter (cf. FIG. 5), which preferably is introduced into the ascending aorta via a femoralis artery.
  • the optionally introduced arterial infusion catheter can either be used alone or together with another arterial infusion catheter, for example together with an arterial infusion catheter introduced via the left or right arteria subclavia.
  • FIG. 5 an exemplifying embodiment of a double lumen catheter 500 is shown.
  • the double lumen catheter has an outer diameter of about 2.7 mm and a first inner lumen 501 having a diameter of about 2.1 mm.
  • a second inner lumen 502 having a diameter of about 0.3 mm.
  • the distal end of the catheter tapers over a distance of about 3 cm to 1.3 mm still containing the small second inner lumen.
  • the large first inner lumen ends about 4 cm from the tip.
  • the catheter is shaped as a right coronary artery catheter. Extending from the catheter tip and over a distance of approximately 5 cm are a number, for example eight, side holes 503 to the greater lumen of the catheter arranged along the greater curvature of the catheter.
  • the side holes have a diameter of about 1.5 mm.
  • the tip of the catheter 500 When the catheter is in position, the tip of the catheter 500 is positioned slightly above the entrance of the left coronary artery and the side holes to the greater lumen are arranged against the right brachiocephalic artery and left carotid artery.
  • an infusion solution such as temperature controlled or regulated blood or a temperature controlled solution at high infusion rate (5-10 ml per second)
  • the infusion solution will flow through the holes 503 against the right brachiocephalic and left carotid artery, whereby rather selective cooling of the brain can be achieved for inducing or maintaining temperature control.
  • the catheter 500 can be advanced some further centimeters, whereby the tip enters the left coronary artery and pharmacological compounds or radiological contrast may be administered locally to the heart by means of the second inner lumen 502.
  • At least one temperature sensor or a thermistor is in step 1306 inserted preferably percutaneously into a jugular vein, whereby the temperature of the blood in the vein can be measured.
  • two temperature sensors are arranged in vena jugularis, sinister and dexter, respectively.
  • the temperature sensors good temperature regulation of the brain is supported.
  • the thermistor gives off a signal that reflects the temperature of the blood leaving the brain, thus indicating the temperature of the brain or brain hemisphere being thermally regulated.
  • the thermistor preferably consists of some suitable disposable material, which preferably is heparinized. The dimensions of the part inserted into the vena jugularis interna should be small enough to prevent any significant obstruction of the venous blood flow.
  • the output of the thermistor may be used in different ways.
  • the signal is transferred to a regulator, which controls the heat exchanger or the circulation pump or both, in order to achieve a regulated temperature level in the selected brain hemisphere.
  • the signal may be transferred to an indicating device, such as a visual display showing the current temperature of the blood in the vena jugularis interna, and hence the approximate temperature of the brain or the selected brain hemisphere.
  • the extraction catheter is connected to the arterial cannula, i.e. the return device or the arterial infusion catheter, via a perfusion pump, a heat exchanger and possibly also a regulator regulating the oxygenation of the blood, thereby establishing an extra-corporeal circulation circuit for temperature regulated blood.
  • a perfusion pump i.e. the return device or the arterial infusion catheter
  • a heat exchanger possibly also a regulator regulating the oxygenation of the blood, thereby establishing an extra-corporeal circulation circuit for temperature regulated blood.
  • a blood conduit such as a blood tube
  • the blood tube preferably consists of an internally heparinized biocompatible plastic material, and has a diameter suited to its purpose.
  • the blood tube passes through a circulation pump according to prior art, a so-called perfusion pump, preferably equipped with rollers exerting a peristaltic effect externally on the tube.
  • the blood tube extends from the pump to a heat exchanger, which in this particular embodiment is arranged for cooling the blood, but which in another embodiment may be arranged for heating it or it can be arranged for both heating and cooling.
  • a heat exchanger which in this particular embodiment is arranged for cooling the blood, but which in another embodiment may be arranged for heating it or it can be arranged for both heating and cooling.
  • the blood tube passes through a device which supplies or removes heat energy from the blood through the walls of the blood tube.
  • the blood tube is attached to a heparinized heat-exchanging bag with blood canals, providing a large surface area for heating/cooling.
  • the heat exchanger should be capable of regulating blood to a temperature between 0 and 37 degrees Celsius. In some cases, a small temperature fall of only a few degrees is desirable, for example a cooUng to 34 degrees Celsius. In other cases a larger temperature fall is desirable, such as down to 0-5 degrees Celsius. Within other areas of application, a heating of the blood may be desirable, such as from 37 degrees Celsius to about 40 degrees Celsius. As the brain or selected brain hemisphere is cooled/heated, the general body temperature also falls/rises, and accordingly the temperature of the extracted blood. The heat exchanger is therefore controlled so as to keep the blood returned to the body after cooling/heating at the desired temperature.
  • the blood conduit may be attached to a per se known oxygenator or a deoxygenator, before or after the heat exchanger, in order to oxygenate or to deoxygenate the blood.
  • One outlet end of the extra-corporeal blood circuit is attached to the proximal end of the arterial infusion catheter reaching into the right arteria subclavia, truncus brachiocephalicus, ascending aorta or arteria carotis communis, from the heat exchanger or in relevant cases from the oxygenator or deoxygenator, which completes the configuration of the temperature controlling system and makes it ready for use.
  • the circulation pump is placed in the proximity of the place of extraction of blood, but it can also be placed elsewhere in the extra-corporeal blood circuit, for example immediately before the blood return catheter. In such a case, the rest of the blood conduit should be primed before starting the infusion of the infusion solution.
  • priming solution such as a saline solution or blood
  • the blood flow through the shunt 938 is stopped, for example by means of an artery forceps, and the circulation of blood can be started and the temperature of the brain can be monitored by means of a temperature sensor 942 arranged in a jugular vein of the patient 920.
  • a temperature sensor 942 arranged in a jugular vein of the patient 920.
  • the general body temperature also falls, possibly to undesirable levels.
  • a part of the reinfusable blood is in step 310 deviated by way of a Y- formed connector into a heating device and a circulation pump and further introduced into the venous system of the patient.
  • the outlet end of this part of the extra-corporeal blood circuit is attached to the proximal end of the venous infusion catheter.
  • step 1312 venous or arterial blood is circulated extra-corporeally from the patient through the heat exchanger regulating the temperature of the blood and back to the patient.
  • circulation of blood through the extra-corporeal circuit is started, involving the extraction of blood from the vein or artery, cooling or heating it to the desired temperature in the heat exchanger(-s), for example to a temperature between 0 and 37 degrees Celsius, optionally regulating oxygenation by means of an oxygenator, and finally reintroducing it into the patient via the arterial infusion catheter.
  • the temperature controlled blood flows from there into the brain or the affected brain hemisphere, which temperature is controlled swiftly and efficiently.
  • step 1314 the temperature controlled blood is reintroduced into the patient through the arterial infusion catheter arranged in an artery leading blood to the brain, whereby the reintroduced blood regulates the oxygenation and temperature of the brain or the selected brain hemisphere.
  • heated blood having a temperature in the range of 37-40 degrees Celsius, is optionally reintroduced into the patient through the venous infusion catheter, whereby undesired general cooling effects on the rest of the body are diminished.
  • step 1318 the temperature regulated extra-corporeal circulation is maintained at the desired temperature levels of the brain or the affected brain hemisphere for a desired period of time thereafter.
  • the viscosity of the blood can possibly be optimized by infusing a saline solution diluting the blood or by hemofiltration concentrating the blood.
  • step 1322 external cooling by the means of a cooling blanket may be used for the maintenance of the desired temperature over an extended period of time, also after intra-arterial perfusion has been stopped.
  • the blanket may be used for heating the rest of the body during an extended period of intra-arterial perfusion with cooling perfusate, intended for maintenance of local brain hypothermia.
  • FIG. 6a shows schematically an embodiment of the maintained temperature control phase applied in a human patient.
  • An extraction catheter 600 for extraction of blood is introduced into a central vein or artery of a patient, for example in a femoralis vein 602. Further, a venous catheter 604 is inserted into a vein of the patient, for example the right median vein 606.
  • the extraction catheter 600 is further connected to the venous catheter 604 via a perfusion pump 612, an oxygenator/dexoygenator 614 and a temperature regulator 616, whereby a blood circuit is established supplying heated extracted blood to the patient through the venous catheter 604.
  • an arterial infusion catheter 304 is introduced into the truncus brachiocephalica 316 through the right radial artery 306 and via the right subclavian artery 308. Further, the arterial infusion catheter is connected to the extraction catheter 600 via the perfusion pump 612, the oxygenator/deoxygenator 614 and the temperature regulator 616, whereby a blood circuit is established supplying cooled extracted blood to the patient via the truncus brachiocephalica 316.
  • a temperature sensor 608 is introduced into a jugular vein 610 and possibly connected to a control unit 618 regulating the temperature regulator 616 cooling the extracted blood, whereby the cooling of the brain is controlled or monitored.
  • an arterial infusion catheter 500 is inserted into the ascending aorta 314 via the left femoral artery 620 and the aortic arch 312.
  • the cooling blood circuit is established between the extraction catheter 600 and the arterial infusion catheter 500 via the perfusion pump 612, the oxygenator/deoxygenator 614 and the temperature regulator 616.
  • the arterial infusion catheter 500 is the double lumen catheter described with reference to FIG. 5, but it should be understood that the arterial catheter also can be another kind of catheter and alternatively placed in a common carotid artery under the protection of an embolus filter device.
  • FIG. 6c In yet another embodiment of the invention as schematically illustrated in FIG. 6c, three extra-corporeal blood circuits are established.
  • This embodiment of the invention is a combination of the two embodiments previously described with reference to FIGS. 6a and 6b. Firstly, an extra-corporeal blood circuit for heated blood is established between the extraction catheter 600 and the venous infusion catheter 604 via the perfusion apparatus 612, the oxygenator/deoxygenator 614 and the temperature regulating 616. Secondly, an extra-corporeal blood circuit for cooled blood is established between the extraction catheter 600 and the arterial infusion catheter 304 via the perfusion apparatus 612, the oxygenator/deoxygenator 614 and the temperature regulating 616.
  • a third extra-corporeal blood circuit for cooled blood is established between the extraction catheter 600 and the arterial infusion catheter 500 via the perfusion apparatus 612, the oxygenator/ deoxygenator 614 and the temperature regulating 616.
  • a more efficient cooling of the brain is achieved.
  • the perfusion apparatus 616 is arranged to generate a pulsating flow of infusion solution. This pulsating flow is then synchronized to the heart cycle such that the cooled infusion solution flows up in the left and right carotids, 320 and 318, respectively, when the heart is in systole, i.e. when the heart is contracting and pumping blood to the arteries.
  • the infusion catheter described above can be positioned in the internal jugular vein on one side of the neck.
  • the infusion catheter is preferably positioned with its tip directed cranially. This can be accomplished by means of puncturing the internal jugular vein with a needle. A guide wire can then be introduced through the needle and into the vein in the cranial direction and an introducer, e.g. an introducer of approximately 9 French, is placed into the vein.
  • the infusion catheter is a triple lumen balloon catheter 1000, cf. Fig 9, is placed through the introducer and placed with the balloon 1002 at the level of the angle of the mandible.
  • the triple lumen balloon catheter 1000 can for example be an 8 French catheter having a length of approximately 25 centimeters.
  • the three lumens are intended for introduction of a pressure recording means, for infusion of a brain-protective fluid and for inflation/deflation of the balloon.
  • the first lumen 1004 ends approximately 1.5 cm proximally of the catheter tip.
  • a Y-connector can be attached to preferably the stopcock of a second lumen 1006 of the catheter 1000.
  • a temperature sensor e.g. a thin wire with a thermistor
  • the measured temperature can further be an indication of the presence of systemic blood, i.e. that the balloon does not seal off the vein, since this systemic blood will heat a cooled infusion fluid.
  • the thermistor may be preimbedded into the material composing the catheter 1000.
  • Cold cristalloid solution is infused through a second lumen 1006 of the catheter 1000 with its balloon 1002 inflated, which balloon 1002 is inflated and deflated by means of a third lumen 1008.
  • the infusion rate is regulated in order not to have the vein pressure to exceed about 25 mniHg.
  • the infusion of cristalloid solution is subsequently followed by the infusion of blood extracted from the remaining jugular veins or the femoral veins or arteries.
  • the blood has passed through a cooler, possibly a pump and possibly an oxygenator/deoxygenator passed to the catheter in the jugular vein.
  • a double lumen catheter e.g. an approximately 16 French double lumen catheter
  • a first lumen ends approximately 25 mm from the tip of the catheter.
  • a thermistor at the opening of the first lumen is recording the temperature of the blood in the distal part of the inferior vena cava.
  • Blood is then aspirated from the first lumen with a pump, passed through a heater and infused through the tip of the infusion catheter via a second lumen of the infusion catheter. Temperature is in this way automatically regulated in the inferior vena cava to stay between approximately 37 and 36 degrees Celsius.
  • blood can also extracted from a femoral artery and the blood flow from the femoral artery can be controlled by a flow controller (not shown) arranged at the catheter in the internal vena jugularis causing the blood to flow due to the pressure difference in the artery and the vein, respectively.
  • a flow controller not shown
  • the pump is not necessary.
  • a double lumen catheter can be introduced into the superior vena cava via the other internal vena jugularis .
  • the temperature regulating device or temperature regulator 700 comprises a peltier element 702 and a heat exchanger such as a tube or a conduit 704 of for example folded, twisted or wrinkled stainless steel or another material able to transfer thermal energy.
  • the conduit 704 confines a passage 706 for fluid to be temperature regulated.
  • the conduit 704 has an inlet 710 for fluid to be temperature regulated and an outlet 712 for temperature regulated fluid. If the fluid is to be cooled the conduit 704 should be arranged on the cool side of the peltier element 702 and if the fluid is to be heated the conduit 704 should be arranged on the hot side of the peltier element 702.
  • a cooling flange 720 is further arranged at the hot side of the peltier element 702, which cooling flange 720 is connected to a fan or another cooling device, e.g. a ventilator 722, whereby the hot side of the peltier element 702 is cooled.
  • the temperature regulating device 700 is used for both cooling and heating a fluid.
  • the temperature regulating device 700 is designed as a double heat exchanger comprising a peltier element 702 and two conduits 704,704' confining passages 706,706' having inlets 710,710' and outlets 712,712'.
  • fluid passing though the passages 706,706' is cooled and heated, respectively.
  • the temperature regulating device 700 is provided with a power supply 716 supplying power to the peltier element and a control unit 718 controlling the temperature regulation.
  • the conduit 704 or the conduits 704,704' is/are provided with a plastic or plastic-like housing or cover 708 or covers 708, 708', by means of which the conduit 704 or conduits 704,704' is/are arranged to be attachable and detachable at the peltier element 702.
  • the conduit 704,704' and the cover 708,708' is preferably manufactured as a disposable or disposables, preferably as a sterile disposable or disposables provided with for example an anticoagulant agent on the inner surface of the conduit 704,704'.
  • the temperature regulating device 700 is manufactured as a disposable and preferably as a disposable having sterile inner surfaces of the conduit 704,704' not to contaminate the fluid to be temperature regulated and inner surfaces provided with an anticoagulant agent.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Thermal Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)

Abstract

Cette invention, qui a trait à une technique, ainsi qu'à l'équipement correspondant, de surveillance de la température cérébrale ou de la température d'un hémisphère cérébral, concerne, plus particulièrement, une technique et l'équipement correspondant, permettant de surveiller, rapidement et efficacement, la température cérébrale ainsi que de conserver au cerveau une température basse. Cette technique se subdivise en trois étapes. Il s'agit, dans un premier temps, d'une surveillance d'urgence de la température de l'ensemble du corps, permettant une surveillance, notamment sur les lieux d'un accident. La deuxième étape de surveillance sélective de la température cérébrale permet de contrôler celle-ci plus efficacement, notamment en salle d'urgence, et la troisième étape de surveillance du maintien en l'état de la température, permet un contrôle encore plus efficace de la température durant une période prédéterminée.
PCT/SE2003/000187 2000-06-05 2003-02-05 Surveillance de la temperature cerebrale WO2003066137A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP03703603A EP1480693A1 (fr) 2002-02-05 2003-02-05 Surveillance de la temperature cerebrale
CA002476382A CA2476382A1 (fr) 2002-02-05 2003-02-05 Surveillance de la temperature cerebrale
AU2003206313A AU2003206313A1 (en) 2002-02-05 2003-02-05 Cerebral temperature control
US10/502,574 US20060052854A1 (en) 2000-06-05 2003-02-05 Cerebral temperature control

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/072,857 2002-02-05
US10/072,857 US20020161349A1 (en) 2000-06-05 2002-02-05 Cerebral temperature control

Publications (1)

Publication Number Publication Date
WO2003066137A1 true WO2003066137A1 (fr) 2003-08-14

Family

ID=27732324

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE2003/000187 WO2003066137A1 (fr) 2000-06-05 2003-02-05 Surveillance de la temperature cerebrale

Country Status (4)

Country Link
EP (1) EP1480693A1 (fr)
AU (1) AU2003206313A1 (fr)
CA (1) CA2476382A1 (fr)
WO (1) WO2003066137A1 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7824436B2 (en) 2005-05-13 2010-11-02 Benechill, Inc. Methods and devices for non-invasive cerebral and systemic cooling
US8157767B2 (en) 2009-06-19 2012-04-17 Benechill, Inc. Devices for cooling the nasal cavity
EP2134304A4 (fr) * 2007-03-23 2012-09-12 Thermal Therapeutic Systems Inc Dispositif d'hyperthermie portable
US8608696B1 (en) 2009-02-24 2013-12-17 North Carolina State University Rapid fluid cooling devices and methods for cooling fluids
US8721699B2 (en) 2005-05-13 2014-05-13 Benechill, Inc. Methods and devices for non-invasive cerebral and systemic cooling
US9358150B2 (en) 2005-05-13 2016-06-07 Benechill, Inc. Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance
CN111419528A (zh) * 2020-04-20 2020-07-17 首都医科大学宣武医院 低温治疗导管和低温治疗系统

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906588A (en) * 1990-12-28 1999-05-25 Cardeon Corporation Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon and associated method
US6042559A (en) * 1998-02-24 2000-03-28 Innercool Therapies, Inc. Insulated catheter for selective organ perfusion
US6110139A (en) * 1997-10-21 2000-08-29 Loubser; Paul Gerhard Retrograde perfusion monitoring and control system
WO2001093922A1 (fr) * 2000-06-05 2001-12-13 Argmed Kommanditbolag Methode et appareil de regulation de la temperature cerebrale
US6383172B1 (en) * 1999-04-02 2002-05-07 Coaxia, Inc. Retrograde venous perfusion with isolation of cerebral circulation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906588A (en) * 1990-12-28 1999-05-25 Cardeon Corporation Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon and associated method
US6110139A (en) * 1997-10-21 2000-08-29 Loubser; Paul Gerhard Retrograde perfusion monitoring and control system
US6042559A (en) * 1998-02-24 2000-03-28 Innercool Therapies, Inc. Insulated catheter for selective organ perfusion
US6383172B1 (en) * 1999-04-02 2002-05-07 Coaxia, Inc. Retrograde venous perfusion with isolation of cerebral circulation
WO2001093922A1 (fr) * 2000-06-05 2001-12-13 Argmed Kommanditbolag Methode et appareil de regulation de la temperature cerebrale

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9775741B2 (en) 2005-05-13 2017-10-03 Braincool Ab Methods and devices for non-invasive cerebral and systemic cooling
US7837722B2 (en) 2005-05-13 2010-11-23 Benechill, Inc. Methods and devices for non-invasive cerebral and systemic cooling
US8075605B2 (en) 2005-05-13 2011-12-13 Benechill, Inc. Methods and devices for treatment of migraines
US7824436B2 (en) 2005-05-13 2010-11-02 Benechill, Inc. Methods and devices for non-invasive cerebral and systemic cooling
US8480723B2 (en) 2005-05-13 2013-07-09 Benechill, Inc. Methods and devices for non-invasive cerebral and systemic cooling
US10561527B2 (en) 2005-05-13 2020-02-18 Braincool Ab Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance
US8721699B2 (en) 2005-05-13 2014-05-13 Benechill, Inc. Methods and devices for non-invasive cerebral and systemic cooling
US9358150B2 (en) 2005-05-13 2016-06-07 Benechill, Inc. Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance
EP2134304A4 (fr) * 2007-03-23 2012-09-12 Thermal Therapeutic Systems Inc Dispositif d'hyperthermie portable
US8608696B1 (en) 2009-02-24 2013-12-17 North Carolina State University Rapid fluid cooling devices and methods for cooling fluids
US8808241B2 (en) 2009-02-24 2014-08-19 North Carolina State University Rapid fluid cooling devices and methods for cooling fluids
US8157767B2 (en) 2009-06-19 2012-04-17 Benechill, Inc. Devices for cooling the nasal cavity
US10076441B2 (en) 2009-06-19 2018-09-18 Braincool Ab Devices for cooling the nasal cavity
US8512280B2 (en) 2009-06-19 2013-08-20 Benechill, Inc. Devices for cooling the nasal cavity
CN111419528A (zh) * 2020-04-20 2020-07-17 首都医科大学宣武医院 低温治疗导管和低温治疗系统

Also Published As

Publication number Publication date
EP1480693A1 (fr) 2004-12-01
CA2476382A1 (fr) 2003-08-14
AU2003206313A1 (en) 2003-09-02

Similar Documents

Publication Publication Date Title
US20060052854A1 (en) Cerebral temperature control
US7189253B2 (en) Cerebral temperature control
US5906588A (en) Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon and associated method
JP4456764B2 (ja) 熱交換留置カテーテル用冷却システム
US6648906B2 (en) Method and apparatus for regulating patient temperature by irrigating the bladder with a fluid
US6572640B1 (en) Method and apparatus for cardiopulmonary bypass patient temperature control
US9180236B2 (en) Intra-aortic balloon counterpulsation with concurrent hypothermia
US20020032430A1 (en) Method and system for treating stroke using hypothermia
US20160175513A1 (en) Localized Therapy Delivery and Local Organ Protection
WO2010111778A4 (fr) Appareil, système et procédés de traitement sanguin extracorporel pour refroidir de manière sélective le cerveau par rapport au corps pendant un traitement hyperthermique ou pour induire une hypothermie du cerveau
CN115052651B (zh) 输注导管和使用方法
JP3688998B2 (ja) 無血処置装置
WO2003066137A1 (fr) Surveillance de la temperature cerebrale
US20160184505A1 (en) Patient warming system
CN117653488B (zh) 一种新型epr动物实验平台及其使用方法
CN116392664A (zh) 一种心肌灌注冠状动脉的再灌注系统及控制方法

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2006052854

Country of ref document: US

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 10502574

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2003206313

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2476382

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003703603

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003703603

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10502574

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2003703603

Country of ref document: EP